Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Application of Budesonide Enteric-coated Capsules in the Treatment of Primary IgA Nephropathy.

NCT07585981 is registered in ClinicalTrials.gov with Chinese PLA General Hospital as lead sponsor.

NCT NCT07585981
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07585981 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Application of Budesonide Enteric-coated Capsules in the Treatment of Primary IgA Nephropathy.
Lead sponsor
Chinese PLA General Hospital
Phase
Observational
Overall status
Recruiting
Start date
October 20, 2025
Completion date
October 1, 2027
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

iga glomerulonephritis